NJC
Paper
incubated at 37 1C in a humidified atmosphere containing 5% CO2 European Regional Development Fund in the framework of
(standard conditions). Cells were passaged at preconfluent density, the Polish Innovation Economy Operational Program (contract
using a solution containing 0.05% trypsin and 0.5 mM EDTA. All no. POIG.02.01.00-12-023/08).
cell culture fluids were purchased from IMMUNIQ (Poland).
Cytotoxicity assay. Cells were seeded in the 96-well plate at a
density of 10 000 cells per ml and incubated for 24 h under
standard conditions. After that time, the culture medium was
Notes and references
changed for the tested compounds at a final concentration of
0.1–0.001 mM in PBS (IMMUNIQ, Poland). Cells with com-
pounds were incubated for 4 h, then washed with PBS and
finally a new medium was added. After 24 h of incubation the
cytotoxicity was assessed.
1 World Health Organization. The evolving threat of antimicrobial
resistance – Options for actions 2012 (WHO/IER/PSP/2012.2).
2 G. Alvan, C. Edlund and A. Heddini, Drug Resist. Updates,
2011, 14, 70–76.
´
3 A. Bykowska, R. Starosta, A. Brzuszkiewicz, B. Ba˙zanow,
´
´
The cytotoxicity of the tested compounds was determined by
the MTT assay. Briefly, 200 ml of MTT (5 mg mlꢀ1, Sigma-
Aldrich) was added to each of the wells and incubated for 4 h at
room temperature. Then the blue formazan reaction product
formed was dissolved in 100 ml of DMSO–CH3OH mixture
(1/1; v/v). The absorbance of the formazan solution was mea-
sured at 565 nm using an Infinite 200M PRO NanoQuant plate
reader (Tecan, Switzerland).
The results were determined as a cell survival fraction, S/S0
(%) and were calculated using the formula: S/S0 (%) = [abs565nm
of treated cells/abs565nm of untreated cells (control)] ꢃ 100.
Untreated cells, cultured only in medium, were treated as a
control. IC50 values (concentration of the tested agent causing
50% inhibition of cell growth) were calculated from the con-
M. Florek, N. Jackulak, J. Krol, J. Grzesiak, K. Kalinski and
M. Je˙zowska-Bojczuk, Polyhedron, 2013, 60, 23–29.
4 H. Coates, P. A. T. Hoye, US Pat., 3 035 053, 1962.
5 A. A. Karasik, I. O. Georgiev, E. I. Musina, O. G. Sinyashin
and J. Heinicke, Polyhedron, 2001, 20, 3321–3331.
´
6 R. Starosta, M. Florek, J. Krol, M. Puchalska and A. Kochel,
New J. Chem., 2010, 34, 1441–1449.
7 C. Marzano, M. Pellei, F. Tisato and C. Santini, Anti-Cancer
Agents Med. Chem., 2009, 9, 185–211.
8 S. J. Berners-Price and P. J. Sadler, Bioinorg. Chem., 1988, 70,
27–102.
9 R. Starosta, K. Stokowa, M. Florek, J. Krol, A. Chwiłkowska,
J. Kulbacka, J. Saczko, J. Skała and M. Je˙zowska-Bojczuk,
J. Inorg. Biochem., 2011, 105, 1102–1108.
´
structed dose–response curve presenting the effect of different 10 F. J. Ramos-Lima, A. G. Quiroga, J. M. Perez, M. Font-Bardia,
concentrations and cell surviving fraction after treatment with
the studied compounds. All data are represented as the mean
values of three independent experiments.
X. Solans and C. Navarro-Ranninger, Eur. J. Inorg. Chem.,
2003, 1591–1598.
11 K. Neplechova, J. Kasparova, O. Vrana, O. Novakova,
A. Habtemarian, B. Watchman, P. J. Sadler and V. Brabec,
Mol. Pharmacol., 1999, 56, 20–30.
Fluorescence microscopy. Viable and dead cells were detected
by staining with acridine orange (AO, 5 mg Lꢀ1) and propidium
iodide (PI, 5 mg Lꢀ1) for 20 min and examined using a fluorescence 12 W. Henderson and S. R. Alley, Inorg. Chim. Acta, 2001, 322,
inverted microscope (Olympus IX51, Japan) with an excitation filter
of 470/20 nm. Photographs of the cells after treatment with the 13 C. F. Shaw, Chem. Rev., 1999, 99, 2589–2600.
14 P. M. Hawkey, J. Antimicrob. Chemother., 2003, 51, 29–35.
106–112.
tested compounds were taken under a magnification of 20ꢃ.
Statistical analysis. For the determination of the significant 15 D. C. Hopper, Drugs, 1999, 58, 6–10.
difference between the percentage of survival rate of cell lines in the 16 K. Drlica, Curr. Opin. Microbiol., 1999, 2, 504–508.
presence of the studied compounds at their various concentrations 17 B. D. Bax, P. F. Chan, D. S. Eggleston, A. Fosberry, D. R. Gentry,
the Tukey HSD test of ANOVA/MANOVA (using STATISTICA for
Windows; StatSoft, Tulsa, OK, USA) was used. The numbers of
colony-forming units per culture (CFU) from the biological assays
were converted to percentage survival values, where the inoculum
of eukaryotic cells in the control sample without the tested
F. Gorrec, I. Giordano, M. M. Hann, A. Hennessy, M. Hibbs,
J. Huang, E. Jones, J. Jones, K. Koretke Brown, C. J. Lewis,
E. W. May, M. R. Saunders, O. Singh, C. E. Spitzfaden, C. Shen,
A. Shillings, A. J. Theobald, A. Wohlkonig, N. D. Pearson and
M. N. Gwynn, Nature, 2010, 466, 935–940.
chemiotherapeutic agents was set at 100% and values for the 18 T. Kloskowski, N. Gurtowska and T. Drewa, Pulm. Pharma-
survival rates were expressed as % CFU. P values less than or equal col. Ther., 2010, 23, 373–375.
to 0.05 indicate that the values compared are statistically signifi- 19 T. Kloskowski, N. Gurtowska, M. Nowak, R. Joachimiak,
cantly different at a 95% confidence level.
A. Bajek, J. Olkowska and T. Drewa, Acta Physica Polonica B,
2011, 42, 859–865.
20 D. J. Smart, D. Halicka, F. Traganos, Z. Darzynkiewicz and
G. M. Williams, Cancer Biol. Ther., 2008, 7, 113–119.
Acknowledgements
´
21 R. Starosta, B. Ba˙zanow and W. Barszczewski, Dalton Trans.,
The authors gratefully acknowledge financial support from
2010, 39, 7547–7555.
the Polish National Science Centre (grant 2011/03/B/ST5/ 22 K. D. Cooney, T. R. Cundari, N. W. Hoffman, K. A. Pittard,
01557). The in vitro research was carried out with the equip-
M. D. Temple and Y. Zhao, J. Am. Chem. Soc., 2003, 125,
ment purchased thanks to the financial support of the
4318–4324.
1070 | New J. Chem., 2014, 38, 1062--1071
This journal is ©The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2014